Multi-lineage expansion potential of primitive hematopoietic progenitors: Superiority of umbilical cord blood compared to mobilized peripheral blood

Experimental Hematology

Volumn 28, Issue 9, 2000, Pages 1087-1095

  Lewis, Ian D ^a   Verfaillie, Catherine M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

AFT024; Cord blood; Expansion; Hematopoiesis; Multi lineage

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; INTERLEUKIN 7; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; ARTICLE; BLOOD; CELL DIFFERENTIATION; CELL LINEAGE; COMPARATIVE STUDY; CONTROLLED STUDY; FETUS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE; PROMYELOCYTE; TISSUE EXPANSION; UMBILICAL CORD BLOOD;

ANIMAL; ANTIGENS, CD34; CELL DIVISION; CELL LINE; CELL LINEAGE; COCULTURE; COMPARATIVE STUDY; CYTOKINES; FETAL BLOOD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMAN; KILLER CELLS, NATURAL; MICE; STEM CELLS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0033801832     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00515-4     Document Type: Article

References (50)

1. Ploemacher R.E., van der Sluijs J.P., Voerman J.S.A., Brons N.H.C. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 74:1989;2755.
2. Sutherland H.J., Lansdorp P.M., Henkelman D.H., Eaves A.C., Eaves C.J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A. 87:1990;3584.
3. Larochelle A., Vormoor J., Hanenberg H.et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow. implications for gene therapy Nat Med. 2:1996;1329.
4. - cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1α maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay. Blood. 91:1998;4516.
5. Burroughs J., Gupta P., Blazar B.R., Verfaillie C.M. Diffusible factors from the murine cell line M2-10B4 support human in vitro hematopoiesis. Exp Hematol. 22:1994;1095.
6. Verfaillie C.M., Catanzaro P. Direct contact with stroma inhibits proliferation of human long-term culture initiating cells. Leukemia. 10:1996;498.
7. Gupta P., Oegema T.R. Jr., Brazil J.J., Dudek A.Z., Slungaard A., Verfaillie C.M. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood. 92:1998;4641.
8. Punzel M., Gupta P., Roodell M., Mortari F., Verfaillie C.M. Factor(s) secreted by AFT024 fetal liver cells following stimulation with human cytokines are important for human LTC-IC growth. Leukemia. 13:1999;1079.
9. Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A. 94:1997;9836.
10. Bhatia M., Bonnet D., Kapp U., Wang J.C.Y., Murdoch B., Dick J.E. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 186:1997;619.
11. + cord blood cells after ex vivo expansion. evidence for the amplification and self-renewal of repopulating stem cells Blood. 93:1999;3736.
12. - primitive progenitor cells. Blood. 88:1996;1619.
13. Kobayashi M., Laver J.H., Kato T., Miyazaki H., Ogawa M. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood. 88:1996;429.
14. Ku H., Yonemura Y., Kaushansky K., Ogawa M. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood. 87:1996;4544.
15. Broudy V.C. Stem cell factor and hematopoiesis. Blood. 90:1997;1345.
16. Lyman S.D., Jacobsen S.E.W. c-kit ligand and Flt3 ligand. stem/progenitor cell factors with overlapping yet distinct activities Blood. 91:1998;1101.
17. + cells purified from cord blood and fetal liver. Exp Hematol. 23:1995;422.
18. Itoh K., Tezuka H., Sakoda H.et al. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol. 17:1989;145.
19. Sutherland H.J., Eaves C.J., Lansdorp P.M., Thacker J.D., Hogge D.E. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood. 78:1991;666.
20. Verfaillie C.M., Catanzarro P.M., Li W.-N. Macrophage inflammatory protein 1α, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med. 179:1994;643.
21. Moore K.A., Ema H., Lemischka I.R. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood. 89:1997;4337.
22. - progenitors to maintain primitive function and immunophenotype in vitro. Exp Hematol. 26:1998;612.
23. Punzel M., Moore K.A., Lemischka I.R., Verfaillie C.M. The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells. Leukemia. 13:1999;92.
24. Mayani H., Lansdorp P.M. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells. 16:1998;153.
25. Verfaillie C.M. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood. 79:1992;2821.
26. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 126:1981;1614.
27. - cells and maintains progenitor cells in vitro. Blood. 87:1996;3563.
28. Veiby O.P., Jacobsen F.W., Cui L., Lyman S.D., Jacobsen S.E.W. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-α and TGF-β J Immunol. 157:1996;2953.
29. -) human bone marrow progenitor cells. distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-β and TNF-α J Immunol. 158:1997;5169.
30. Zandstra P.W., Conneally E., Petzer A.L., Piret J.M., Eaves C.J. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A. 94:1997;4698.
31. - cells with preserved ability to engraft SCID-hu bone. Blood. 91:1998;1206.
32. Punzel M., Wissink S.D., Miller J.S., Moore K.A., Lemischka I.R., Verfaillie C.M. The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro. Blood. 93:1999;3750.
33. -) human hematopoietic cells. novel responses to Flt3-ligand and thrombopoietin J Exp Med. 183:1996;2551.
34. Piacibello W., Sanavio F., Garetto L.et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 89:1997;2644.
35. Whitlock C.A., Witte O.N. Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci U S A. 79:1982;3608.
36. + NK progenitor Blood. 83:1994;2594.
37. Dittel B.N., LeBien T.W. The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol. 154:1995;58.
38. Prosper F., Stroncek D., Verfaillie C.M. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood. 88:1996;2033.
39. Hogge D.E., Lansdorp P.M., Reid D., Gerhard B., Eaves C.J. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood. 88:1996;3765.
40. Prosper F., Vanoverbeke K., Stroncek D., Verfaillie C.M. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow. Blood. 89:1997;3991.
41. Miller J.S., Prosper F., McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood. 90:1997;3098.
42. - progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 93:1999;96.
43. + mobilized peripheral blood stem cells. Blood. 91:1998;111.
44. Hao Q.L., Thiemann F.T., Petersen D., Smogorzewska E.M., Crooks G.M. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood. 88:1996;3306.
45. Bhatia M., Wang J.C.Y., Kapp U., Bonnet D., Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 94:1997;5320.
46. + cells. Exp Hematol. 26:1998;353.
47. - cells stimulated by multiple growth factors in vitro. Blood 94:1926.
48. Ziegler B.L., Valtieri M., Almeida Porada G.et al. KDR receptor. a key marker defining hematopoietic stem cells Science. 285:1999;1553.
49. Almici C., Carlo-Stella C., Wagner J.E.et al. Clonogenic capacity and ex-vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation. Bone Marrow Transplant. 19:1997;1079.
50. Shlebak A.A., Marley S.B., Roberts I.A., Davidson R.J., Goldman J.M., Gordon M.Y. Optimal timing for processing and cryopreservation of umbilical cord blood haematopoietic stem cells for clinical transplantation. Bone Marrow Transplant. 23:1999;131.